Innovation in biomaterials has transformed the design and performance of implantable medical devices. New metal alloys, advanced polymers, technical ceramics and bioactive coatings are enabling the development of implants that are more durable, biocompatible and adapted to today’s clinical requirements.
However, before a biomaterial can be used in a surgical implant, it must pass a rigorous technical, biomechanical and biological validation process, aligned with Regulation (EU) 2017/745 (MDR). In this article, we explain how biomaterials are evaluated prior to implantation and which tests are essential to ensure their safety and performance.
What is considered a biomaterial in medical devices?
A biomaterial is any material designed to interact with biological systems for therapeutic or diagnostic purposes. In implantable medical devices, biomaterials must simultaneously meet the requirements of:
- biocompatibility,
- mechanical resistance,
- chemical stability,
- long-term durability,
- compatibility with manufacturing and sterilization processes.
These materials must not only be safe in isolation, but also maintain their performance when part of a complete device.
Types of biomaterials used in implants
Biomaterials innovation encompasses different families, each with specific validation challenges.
| Type of biomaterial | Common examples | Common applications |
|---|---|---|
| Metallics | Ti6Al4V, CoCr, stainless steel | Joint prostheses, bone plates |
| Ceramics | Alumina, zirconia | Joint components, femoral heads |
| Polymerics | PEEK, UHMWPE | Acetabular components, fixations |
| Bioactives | Hydroxyapatite, calcium phosphates | Osseointegrative coatings |
| Compounds | Multilayer, hybrids | New generation implants |
Each category requires specific tests, as their behavior under load, wear or biological environment is different.
Why pre-implementation validation is critical
An innovative biomaterial may offer theoretical advantages, but without proper validation it may generate serious risks, such as:
- implant fracture,
- accelerated wear,
- particle release,
- adverse tissue reactions,
- premature failure in clinical use.
Therefore, the MDR requires demonstrating that the selected materials are safe and suitable for the intended use, supported by objective data obtained through standardized testing and scientific evaluation.
Key mechanical testing in the validation of biomaterials
The mechanical tests make it possible to verify that the biomaterial supports the real loads to which the implant will be subjected.
| Type of test | Target | Standard rules |
|---|---|---|
| Tensile and compression tests | Determine strength and yield strength | ISO 6892, ASTM E8 |
| Fatigue tests | Evaluate behavior under cyclic loading | ISO 7206-4, ASTM F384 |
| Bending tests | Analyze structural stiffness | ISO 9585, ASTM F382 |
| Wear tests | Measuring material loss | ISO 14242, ASTM F732 |
| Adhesion tests | Validate coatings | ASTM F1147, ASTM F1044 |
These tests are particularly relevant for implants subjected to millions of load cycles, such as joint prostheses or osteosynthesis systems.
Biological and chemical evaluation of the biomaterial
In addition to mechanical behavior, the biomaterial must demonstrate that it is biologically safe. The ISO 10993 series establishes the reference framework for this evaluation.
| Type of evaluation | What it analyzes |
|---|---|
| Cytotoxicity | Direct cell damage |
| Awareness | Allergic reactions |
| Irritation | Local tissue response |
| Systemic toxicity | Effects on the organism |
| Chemical degradation | Long-term stability |
In degradable or bioactive materials, degradation kinetics and controlled release of products are also studied.
Relationship between biomaterials, assays and MDR 2017/745.
The MDR requires manufacturers to justify the selection of materials within the technical file by demonstrating that:
- the biomaterial is suitable for the intended use,
- associated risks are identified and mitigated,
- the tests performed are representative,
- the results are traceable and reproducible.
For this reason, the tests used as regulatory evidence are usually performed in ISO/IEC 17025 accredited laboratories, which reinforces the acceptance of the data by the notified bodies.
IBV’s role in the validation of biomaterials
The Biomechanics Institute of Valencia combines the capabilities of:
- advanced mechanical testing,
- analysis of fatigue and wear behavior,
- applied biomechanical evaluation,
- technical support in MDR validation strategies.
This allows manufacturers to validate innovative biomaterials prior to clinical implantation, reducing technical and regulatory risks and accelerating market access.
